US2014315844A1
|
|
Multi-gene signatures for predicting response to chemotherapy or risk of metastasis for breast cancer
|
US2014178362A1
|
|
Methods and compositions for treating diseases targeting maba
|
EP2635709A2
|
|
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
US2011269735A1
|
|
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
WO2010006215A1
|
|
Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
|
WO2010002891A1
|
|
Genetic polymorphisms associated with autoinflammatory diseases, methods of detection and uses thereof
|
CA2717045A1
|
|
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
US2009221620A1
|
|
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
US2009203015A1
|
|
Multiplex assays for hormonal and growth factor receptors, and uses thereof
|
US2009162348A1
|
|
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
|
EP2227556A2
|
|
Lung cancer markers and uses thereof
|
US2009130682A1
|
|
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
US2009162346A1
|
|
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
US7842467B1
|
|
Breast disease targets and uses thereof
|
BRPI0811309A2
|
|
polymorphism in the expected receptivity of the apo (a) gene to treatment with acetylsalicylic acid.
|
US2008241846A1
|
|
Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof
|
US7960100B1
|
|
Colon cancer targets and uses thereof
|
US7842466B1
|
|
Colon disease targets and uses thereof
|
CA2674907A1
|
|
A molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
|
US7807392B1
|
|
Lung disease targets and uses thereof
|